Delivery Order SPE2DB20D3101-SPE2DB23FRPU1
- Not listed
- This federal contract award, valued at $96,251.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical product for federal healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of RABAVERT rabies vaccine with diluents (Contract ID: SPE2DX15D3006|SPE2DX23F02YP) with a total ceiling value of $4,448.97. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on May 18, 2023, with a completion date of May 19, 2023. The contract is a firm fixed-price delivery order, and no set-aside designation was used. Amerisourcebergen...
- This federal contract award is for the delivery of RABAVERT Rabies Vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,290.20 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 8, 2021. The contract is not designated as a set-aside. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of RABAVERT rabies vaccine with diluents. The contract has a not-to-exceed value of $10,883.21 and runs through December 20, 2023. It is a firm-fixed price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $20,290.20 for the supply of RABAVERT rabies vaccine with diluents. The award was made by the Defense Logistics Agency (DLA), a defense agency, on August 31, 2022, with a completion date of September 1, 2022. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of RABAVERT rabies vaccine with diluents. The $3,925.13 firm fixed-price delivery order was issued by the Defense Logistics Agency, a defense agency, with an ultimate completion date of April 5, 2023. The contract is not a set-aside and was awarded on a full and open competitive basis. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $7,246.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,558,244,980 units of RabAvert rabies vaccine with diluents, at a ceiling value of $2,898.60. This contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor,...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,951.97 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 29, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has a ceiling value of $3,986.56. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of July 25, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRPU1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of RABAVERT Rabies Vaccine with diluents. The $36,858.00 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a critical supplier of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to federal agencies such as the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.9k | 6/20/23 |